EUVIMEDEUVIMED entdecken
Crossref

Limocitrin increases cytotoxicity of KHYG ‐1 cells against K562 cells by modulating MAPK pathway

Ming-Ju Hsieh iD, Jen-Tsun Lin, Yi-Ching Chuang, Chia-Chieh Lin, Yu-Sheng Lo, Hsin-Yu Ho, Mu-Kuan Chen

Environmental Toxicology · 2023

DOI: 10.1002/tox.23929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Ming-Ju Hsieh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Killer Cells, Natural, Leukemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Science Council, Taiwan, Changhua Christian Hospital, Changhua City, Taiwan, National Science Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are gaining popularity in the field of cancer immunotherapy. The present study was designed to investigate the effect of a natural flavonol compound limocitrin in increasing cytotoxicity of a permanent NK leukemia cell line KHYG‐1 against an aggressive leukemia cell line K562. The findings revealed that limocitrin increased the expressions of cytolytic molecules perforin, granzymes A and B, and granulysin in KHYG‐1 cells by inducing phosphorylation of transcription factor CREB, leading to increased lysis of K562 cells. Mechanistically, limocitrin was found to increase the expressions of t‐Bid, cleaved caspase 3, and cleaved PARP to induce K562 cell apoptosis. Moreover, limocitrin reduced the expressions of SET and Ape1 to inhibit DNA repair mechanism, leading to caspase‐independent K562 cell death. At the molecular level, limocitrin was found to increase the phosphorylation of ERK, p38, and JNK to increase granzyme B expression in KHYG‐1 cells. Taken together, the study indicates that limocitrin increases cytotoxicity of NK cells against a range of cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalLeukemiaHumansK562 CellsPerforinCytotoxicity, Immunologic

Stichwörter der Autor:innen

MAPK signalinggranzyme Blimocitrinnatural killer cellsperforin

Substanzen

Perforin

Autor:innen und Institutionen

  • Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
  • Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Division of Hematology and Oncology, Department of Medicine, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

ORCID-Profile: Ming-Ju Hsieh

Förderung

  • National Science Council, Taiwan
  • Changhua Christian Hospital, Changhua City, Taiwan
  • National Science Council
  • Changhua Christian Hospital

Zitieren

APA

Hsieh, M. J., Lin, J. T., Chuang, Y. C., Lin, C. C., Lo, Y. S., Ho, H. Y., & Chen, M. K. (2023). Limocitrin increases cytotoxicity of KHYG ‐1 cells against K562 cells by modulating MAPK pathway. Environmental Toxicology. https://doi.org/10.1002/tox.23929

Vancouver

Hsieh MJ, Lin JT, Chuang YC, Lin CC, Lo YS, Ho HY, et al. Limocitrin increases cytotoxicity of KHYG ‐1 cells against K562 cells by modulating MAPK pathway. Environmental Toxicology. 2023. doi:10.1002/tox.23929

BibTeX
@article{Hsieh2023,
  author = {Hsieh, Ming-Ju and Lin, Jen-Tsun and Chuang, Yi-Ching and Lin, Chia-Chieh and Lo, Yu-Sheng and Ho, Hsin-Yu and Chen, Mu-Kuan},
  title = {Limocitrin increases cytotoxicity of KHYG ‐1 cells against K562 cells by modulating MAPK pathway},
  journal = {Environmental Toxicology},
  year = {2023},
  doi = {10.1002/tox.23929}
}
Kostenlos starten →